Illumina to Webcast Upcoming Investor Conference
Get Alerts ILMN Hot Sheet
Join SI Premium – FREE
SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:
-
UBS Genomics 2.0 and MedTech Innovations Summit on August 11, 2021
Fireside Chat at 12:00 pm Pacific Time (3:00 pm Eastern Time)
The live webcast can be accessed under the Investor Info section of the "company" tab at www.illumina.com. A replay will be posted on Illumina’s website after the event and will be available for at least 30 days following.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210728006021/en/
Investors:
Brian Blanchett
+1.858.291.6421
[email protected]
Media:
Dr. Karen Birmingham
+1.646.355.2111
[email protected]
Source: Illumina, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Incyte Presents Phase 1/2 Multidose Data for VGA039 (Latarcibart) at ISTH 2026, Showing Substantial Bleed Reductions in Patients with all Von Willebrand Disease Types
- PANIM Emerges from Stealth to Build Distributed Infrastructure for the Next Generation of Artificial Intelligence
- WeRide Accelerates Global Expansion of Its End-to-End Intelligent Driving Solution
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
UBS, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share